The prognostic value of expiratory carbon monoxide level for outcome prediction after myocardial infarction

Abstract

Aims To assess the prognostic value of expiratory carbon monoxide (CO) levels in patients admitted for myocardial infarction (MI). Methods and Results In this prospective study, expiratory CO levels were measured upon admission in consecutive patients hospitalized for MI across 39 centres. The primary outcome was 1-year all-cause death. Secondary outcomes included 1-year major adverse cardiac events (MACEs: cardiovascular death and recurrent MI) and in-hospital major adverse events (MAEs: death, severe ventricular arrhythmia, cardiogenic shock, and the need for mechanical ventilation). The prognostic value of expiratory CO levels was further evaluated using machine learning (ML) analysis. Among 717 patients (64 ± 13 years; 75% males; 33% active smokers; 43% ST-elevation MI), elevated expiratory CO levels (>11 ppm) were found in 79 patients (11%). Patients with elevated CO levels had a higher rate of 1-year all-cause mortality compared with those without (16.5% vs. 5.2%, P < 0.001). El